Brian Grabowski

1.3k total citations
14 papers, 731 citations indexed

About

Brian Grabowski is a scholar working on Nephrology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Brian Grabowski has authored 14 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Brian Grabowski's work include Gout, Hyperuricemia, Uric Acid (6 papers), HIV Research and Treatment (4 papers) and Biochemical and Molecular Research (4 papers). Brian Grabowski is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (6 papers), HIV Research and Treatment (4 papers) and Biochemical and Molecular Research (4 papers). Brian Grabowski collaborates with scholars based in United States, United Kingdom and Japan. Brian Grabowski's co-authors include Reza Khosravan, Laurent Vernillet, Jingtao Wu, Jon F. Denissen, Nancy Joseph‐Ridge, Dale J. Kempf, Samuel Thomas, Gondi Kumar, Hing L. Sham and Bruce W. Surber and has published in prestigious journals such as Virology, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Brian Grabowski

14 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Grabowski United States	10	340	226	204	140	115	14	731
Barry Quart United States	15	232 0.7×	235 1.0×	185 0.9×	331 2.4×	244 2.1×	28	1.2k
Bradley M. Kerr United States	16	285 0.8×	142 0.6×	145 0.7×	120 0.9×	146 1.3×	24	1.4k
Michael Kukulka United States	14	256 0.8×	39 0.2×	187 0.9×	94 0.7×	177 1.5×	28	802
Leonor Pou Spain	17	454 1.3×	81 0.4×	118 0.6×	58 0.4×	192 1.7×	29	900
Eve‐Irene Lepist United States	16	324 1.0×	35 0.2×	125 0.6×	186 1.3×	45 0.4×	22	975
Cheri E. Klein United States	16	293 0.9×	18 0.1×	106 0.5×	123 0.9×	89 0.8×	34	930
Edmund Ho United States	8	355 1.0×	28 0.1×	117 0.6×	127 0.9×	25 0.2×	9	918
Mary Beth Wire United States	18	325 1.0×	21 0.1×	170 0.8×	83 0.6×	32 0.3×	36	957
R Cvetković New Zealand	6	278 0.8×	29 0.1×	85 0.4×	91 0.7×	20 0.2×	10	543
Lillian Ting Canada	15	537 1.6×	17 0.1×	303 1.5×	146 1.0×	96 0.8×	26	1.1k

Countries citing papers authored by Brian Grabowski

Since Specialization

Citations

This map shows the geographic impact of Brian Grabowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Grabowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Grabowski more than expected).

Fields of papers citing papers by Brian Grabowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Grabowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Grabowski. The network helps show where Brian Grabowski may publish in the future.

Co-authorship network of co-authors of Brian Grabowski

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Grabowski. A scholar is included among the top collaborators of Brian Grabowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Grabowski. Brian Grabowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Grabowski, Brian & Ronald Lee. (2012). Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects. Clinical Drug Investigation. 32(5). 319–332. 8 indexed citations

Grabowski, Brian, Reza Khosravan, Jingtao Wu, Laurent Vernillet, & Christopher Lademacher. (2010). Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat, a non‐purine selective inhibitor of xanthine oxidase. British Journal of Clinical Pharmacology. 70(1). 57–64. 20 indexed citations

Grabowski, Brian, Reza Khosravan, Laurent Vernillet, & Darcy J. Mulford. (2010). Metabolism and Excretion of [¹⁴C] Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase, in Healthy Male Subjects. The Journal of Clinical Pharmacology. 51(2). 189–201. 50 indexed citations

Khosravan, Reza, Brian Grabowski, Jingtao Wu, Nancy Joseph‐Ridge, & Laurent Vernillet. (2007). Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects. British Journal of Clinical Pharmacology. 65(3). 355–363. 67 indexed citations

Khosravan, Reza, Brian Grabowski, Jingtao Wu, Nancy Joseph‐Ridge, & Laurent Vernillet. (2006). Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects. Clinical Pharmacokinetics. 45(8). 821–841. 84 indexed citations

Khosravan, Reza, Brian Grabowski, Michael D. Mayer, et al.. (2006). The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase. The Journal of Clinical Pharmacology. 46(1). 88–102. 62 indexed citations

Carr, Robert, Ping Chen, Brian Grabowski, et al.. (2006). The Effect of Hepatic Insufficiency on the Safety and Pharmacokinetics of Paricalcitol (Zemplar<sup>®</sup>). Nephron Clinical Practice. 103(3). c100–c105. 2 indexed citations

Khosravan, Reza, et al.. (2005). Effect of food or antacid on febuxostat pharmacokinetics and pharmacodynamics in healthy subjects. Clinical Pharmacology & Therapeutics. 77(2). P50–P50. 8 indexed citations

Kumar, Gondi, John T. Uchic, Samuel Thomas, et al.. (2004). Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans. Pharmaceutical Research. 21(9). 1622–1630. 90 indexed citations

10.

Kumar, Gondi, Ronald Lee, David N. Whittern, et al.. (1999). In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification. Drug Metabolism and Disposition. 27(1). 86–91. 51 indexed citations

11.

Molla, Akhteruzzaman, Sudthida Vasavanonda, Gondi Kumar, et al.. (1998). Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus. Virology. 250(2). 255–262. 154 indexed citations

12.

Denissen, Jon F., Brian Grabowski, Alex Buko, et al.. (1997). Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.. PubMed. 25(4). 489–501. 115 indexed citations

13.

Kumar, Gondi, et al.. (1996). Hepatic Drug-Metabolizing Activities in Rats after 14 Days of Oral Administration of the Human Immunodeficiency Virus-Type 1 Protease Inhibitor Ritonavir (ABT-538). Drug Metabolism and Disposition. 24(5). 615–617. 9 indexed citations

14.

Denissen, Jon F., Brian Grabowski, Martin Johnson, et al.. (1994). The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.. Drug Metabolism and Disposition. 22(6). 880–888. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact